GlobeNewswire by notified

Transactions in connection with share buy-back program

Share

Announcement

A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program

On 5 May 2021, A.P. Møller - Mærsk A/S (the “Company”) announced a share buy-back program of up to DKK 32bn (around USD 5bn) to be executed over a period of two years. On 12 August 2022 the Company announced an increase in the current share buy-back program from DKK 32bn (around USD 5bn) to DKK 39.3bn (around USD 6bn).

As announced on 3 November 2022, during the third phase of the program running from 3 November 2022 up to 3 May 2023, the Company will buy back A and B shares for an amount of up to DKK 11bn. The third phase of the share buy-back program will be executed under EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”).

The following transactions have been made under the program in the period Monday January 16, 2023 to Friday January 20, 2023:

Number of A sharesAverage purchase price A shares, DKKTransaction value,
A shares, DKK
Accumulated, last announcement (market and A.P. Møller Holding A/S)243,8794,185,206,154
16 January 202353214,814.79327,881,470
17 January 202367814,904.955810,105,560
18 January 202367314,879.197610,013,700
19 January 202367214,541.01199,771,560
20 January 202367914,506.52439,849,930
Total 16-20 January Friday3,23447,622,220
Bought from A.P. Møller Holding A/S*3,43014,725.478950,508,393
Accumulated in third phase of the program (market and A. P. Møller Holding A/S)63,655948,581,884
Accumulated under the program (market and A. P. Møller Holding A/S)250,5434,283,336,767
Number of B sharesAverage purchase price B shares, DKKTransaction value,
B shares, DKK
Accumulated, last announcement (market, A.P. Møller Holding A/S and the Foundation)1,061,93519,136,757,089
16 January 20232,09015,093.839731,546,125
17 January 20232,63415,201.932440,041,890
18 January 20232,75315,184.464241,802,830
19 January 20232,82714,863.183642,018,220
20 January 20232,47614,800.282736,645,500
Total 16-20 January Friday12,780192,054,565
Bought from A.P. Møller Holding A/S*10,24415,027.7341153,944,108
Bought from the Foundation*3,22715,027.742448,494,525
Accumulated in third phase of the program (market, A. P. Møller Holding A/S and the Foundation)254,2103,867,292,270
Accumulated under the program (market, A. P. Møller Holding A/S and the Foundation)1,088,18619,531,250,287

*) According to separate agreements, A.P. Møller Holding A/S and A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond (the Foundation) participates on a pro rata basis to the shares purchased in the share buy-back program.

Page 1 of 2

With the transactions stated above, the Company owns a total of 218,711 A shares and 955,678 B shares as treasury shares, corresponding to 6.28% of the share capital.

Details of each transaction are included as appendix.

Copenhagen, 23 January 2023

Contact persons:

Head of Investor Relations, Sarah Spray, tel. +45 3147 4170
Head of Media Relations, Jesper Løv, tel. +45 6114 1521

Page 2 of 2

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Danske Bank A/S, transactions by persons discharging managerial responsibilities16.4.2024 10:36:32 CEST | Press release

16 April 2024 Notification no. 37/2024 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with the share buy-back program in Danske Bank A/S, APMH Invest A/S continuously sells shares pro rata. For further details, please find the attached templates for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. Contact: Stefan Singh Kailay, Head of Media Relations, tel. +45 45 14 14 00 Attachment APMH Invest AS - sale - 2024.04.15

Danske Bank A/S, ledende medarbejderes transaktioner16.4.2024 10:36:32 CEST | pressemeddelelse

16. april 2024 Indberetning nr. 37/2024 Ændring i aktiebesiddelser hos Danske Banks indberetningspligtige i henhold til EU-forordningen om markedsmisbrug I forbindelse med Danske Bank A/S’ aktietilbagekøbsprogram sælger APMH Invest A/S løbende aktier i Danske Bank A/S pro rata. For yderligere detaljer henvises til de vedhæftede skemaer, hvori transaktioner udført af personer med ledelsesansvar og personer med nær tilknytning til disse skal indberettes og offentliggøres. Kontakt: Stefan Singh Kailay, Head of Media Relations, tel. +45 45 14 14 00 Vedhæftet fil APMH Invest A_S - salg - 2024.04.15

Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline16.4.2024 10:35:00 CEST | Press release

Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV® Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8 bn Boehringer Ingelheim today announced a strong acceleration of its pipeline in 2023, as pivotal trials in key research areas progressed as planned. Research & Development (R&D) investments increased by 14.2% to EUR 5.8 billion. R&D investments were substantial, at 22.5% of net sales. Group net sales rose by 9.7%* to EUR 25.6 billion in 2023, driven by 10.3%* growth in Human Pharma and 6.9%* growth in Animal Health. Both businesses outperformed their markets. In 2023, regulators awarded five additional FDA fast-track designations and one FDA breakthrough therapy designation in the US, as well as one EMA PRIME scheme acceptance in Europe. With a focus on therapeutic research areas in cardiovascular, renal and metabolic diseases (CRM), oncology, respiratory diseases, immunology, mental health,

Aktia's interim report for January–March will be published on Tuesday 30 April 2024 at 8.00 a.m.16.4.2024 10:30:00 CEST | Press release

Aktia Bank Plc Press release 16 April 2024 at 11.30 a.m. Aktia's interim report for January–March will be published on Tuesday 30 April 2024 at 8.00 a.m. Aktia's interim report for January–March 2024 will be published on Tuesday 30 April 2024 at 8.00 a.m. (EEST). The interim report is available at Aktia's website www.aktia.com after the publication. Webcast from the results event A live webcast will be sent from Aktia’s results event on Tuesday 30 April 2024 at 10.30 a.m. Aktia’s CEO Juha Hammarén and CFO Outi Henriksson will be presenting the results. The event will be held in English and can be seen live as a webcast or as a recording after the event at https://aktia.videosync.fi/2024-q1-results. Questions can be asked in writing during the live webcast. The presentation material in English is available at Aktia's website www.aktia.com before the results event. Aktia Bank Plc Further information: Oscar Taimitarha, Director, Investor Relations, tel. +358 40 562 2315 Distribution: Nasd

Aktias delårsrapport för januari–mars publiceras tisdagen 30.4.2024 kl. 8.0016.4.2024 10:30:00 CEST | Pressemelding

Aktia Bank Abp Pressmeddelande 16.4.2024 kl. 11.30 Aktias delårsrapport för januari–mars publiceras tisdagen 30.4.2024 kl. 8.00 Aktias delårsrapport för januari–mars 2024 publiceras tisdagen 30.4.2024 kl. 8.00. Delårsrapporten finns tillgänglig på Aktias webbplats på adressen www.aktia.com efter publiceringen. Webcast-sändning från resultattillställningen En direkt webcast-sändning arrangeras från Aktias resultattillställning tisdagen 30.4.2024 kl. 10.30. Verkställande direktör Juha Hammarén och ekonomi- och finansdirektör Outi Henriksson presenterar resultatet. Tillställningen hålls på engelska och kan ses som en direkt webcast-sändning eller en inspelning efter tillställningen på adressen https://aktia.videosync.fi/2024-q1-results. Frågor kan ställas skriftligt under den direkta webcast-sändningen. Presentationsmaterialet på engelska finns tillgängligt på Aktias webbplats www.aktia.com före resultattillställningen. Aktia Bank Abp Mera information: Oscar Taimitarha, direktör för inves

HiddenA line styled icon from Orion Icon Library.Eye